Financial

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

MINNEAPOLIS, Jan. 21, 2025 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases, today announced that it plans to release fourth quarter 2024 financial and operating results after market close on Tuesday, February…

Aptyx Amplifies Expertise in Complex Interventional Products With Acquisition of Medical Murray’s North Carolina Facility

January 21, 2025 10:10 AM Eastern Standard Time TEMPE, Ariz.–(BUSINESS WIRE)–Aptyx, a leading global developer and manufacturer of complex components and devices for the life sciences, today announced the acquisition of the Charlotte, North Carolina facility of Medical Murray, which develops and produces catheter-based interventional products and transcatheter implants. “This […]

Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program

January 14, 2025 09:00 AM Eastern Standard Time AUSTIN, Texas–(BUSINESS WIRE)–Alleviant Medical, Inc., a privately held medical device company developing a no-implant atrial shunt for heart failure, today announced a $90 million financing to fund its second pivotal trial. Led by Gilde Healthcare, the round also adds Omega Funds and includes participation […]

Scientia Vascular Announces Leadership Transition: John Lippert to Assume CTO Role; Rick Randall Appointed as CEO and Chairman

WEST VALLEY CITY, Utah, Jan. 13, 2025 /PRNewswire/ — Scientia Vascular, a leading innovator in neurovascular medical devices, announces a strategic leadership transition to further drive innovation and growth. Founder and Chief Executive Officer (CEO) John Lippert will transition to the…

BRAIN.Q Achieves CE Mark for Its Breakthrough Therapy for Reducing Disability Following Stroke and Welcomes Stacey Pugh as Chairman of the Board

ENGLEWOOD CLIFFS, N.J., Jan. 13, 2025 /PRNewswire/ — BRAIN.Q, is excited to announce the CE Mark for its BQ 2.0 system, designed to reduce disability following ischemic stroke, the number one cause of disability worldwide. Reducing stroke disability is often achieved through endovascular…